Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Dexamethasone in Hip Arthroscopy
NCT04610398Phase 3Completed
- Sponsor
- University Hospital Balgrist
- Start
- Mar 2021
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain and postoperative nausea and vomiting (PONV) comparing Dexamethasone group with Placebo/ Control group (2 arms). Primary endpoints: Postoperative pain level at 24 hours, Amount of opiates consumed at 48 hours and 1 more. Started Mar 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT04610398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04610398.